Clinical Trials Logo
  1. Home
  2. Motor Neuron Disease
  3. NCT03196375

A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

Motor Neuron Disease Clinical Trial

Official title:
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease

Clinical Trial Summary

The COMMEND Study will assess the safety and effectiveness of FLX-787 in men and women with Motor Neuron Disease [including Amyotrophic Lateral Sclerosis (ALS), Primary Lateral Sclerosis (PLS) or Progressive Muscular Atrophy (PMA)] experiencing muscle cramps. Participants will be asked to take two study products during the course of the study. One of these study products will be a placebo.

Approximately 120 participants in approximately 30 study centers across the United States are expected to take part. Participants will be in the study for approximately 3 months and visit the study clinic 3 times.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03196375
Study type Interventional
Source Flex Pharma, Inc.
Contact
Status Terminated
Phase Phase 2
Start date July 28, 2017
Completion date July 27, 2018
View Details
See also
  Status Clinical Trial Phase
Terminated NCT04579666 - MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS) Phase 2
Completed NCT03706391 - Study of ALS Reversals 4: LifeTime Exposures
Active, not recruiting NCT03067857 - Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease Phase 1/Phase 2
Completed NCT02464748 - Telehealth in Motor Neurone Disease N/A
Completed NCT00956488 - Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis Phase 1/Phase 2
Terminated NCT00537446 - Effect of Noninvasive Ventilation on Lung Function in Amyotrophic Lateral Sclerosis N/A
Recruiting NCT04944940 - Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
Recruiting NCT03362658 - Novel MRI Biomarkers for Monitoring Disease Progression in ALS
Completed NCT00714636 - Cerebrospinal Fluid Repository N/A
Completed NCT00071435 - Brain Function in Primary Lateral Sclerosis N/A
Completed NCT00076687 - Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function Phase 2
Completed NCT00001220 - Ultrasound and Videofluoroscopy for Diagnosing Swallowing Disorders N/A
Completed NCT03487263 - Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease Phase 1
Enrolling by invitation NCT05725759 - Rehabilitation in SOD1 ALS Treated With Tofersen
Active, not recruiting NCT03811301 - [BrainConnexion] - Neurodevice Phase I Trial N/A
Completed NCT02469896 - A Trial of Tocilizumab in ALS Subjects Phase 2
Completed NCT02011204 - Study of Electrical Impedance Myography (EIM) in ALS N/A
Completed NCT01495390 - A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers N/A
Completed NCT02870634 - Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND Phase 1
Recruiting NCT06201650 - Neurofilament Light Chain in Amyotrophic Lateral Sclerosis